Position in PHAT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$434,000
New position
Shares Held
40,000
first reported quarter
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 161 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in PHAT
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$532,735
PutShares
49,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA HOLDINGS INC holds $218,808,046 across 46 Biotechnology names. PHAT ranks #36 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
402,192 | $31,889,803 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
327,475 | $24,390,338 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
61,938 | $19,577,982 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
978,602 | $16,606,875 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
417,932 | $15,216,904 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,198 | $14,503,522 | |
| 7 | OABI |
OmniAb, Inc.
|
5,028,160 | $12,369,273 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,320 | $8,929,092 |
All Filings in PHAT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $532,735 | 49,100 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $434,000 | 40,000 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||